Tandem Diabetes Care (TNDM) EBIT Margin Growth (3y) (2016 - 2026)
Powered by 
Analysis
Tandem Diabetes Care (TNDM) EBIT Margin Growth (3y) (2016 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | -201.00 |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | 722.00 |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | 162.00 |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | 586.00 |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | 736.00 |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | 887.00 |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | -1,075.00 |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | 963.00 |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | 244.00 |
| 10 | Tandem Diabetes Care | 1.26 Bn | 804.14 Mn | 144.78 Mn | 1,439.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1,439.00 |
| Mar 31, 2026 | 6,841.00 |
| Dec 31, 2025 | 1,092.00 |
| Sep 30, 2025 | 1,405.00 |
| Jun 30, 2025 | -1,542.00 |
| Mar 31, 2025 | -4,284.00 |
| Dec 31, 2024 | -627.00 |
| Sep 30, 2024 | -1,499.00 |
| Jun 30, 2024 | -1,702.00 |
| Mar 31, 2024 | -1,945.00 |
| Dec 31, 2023 | -2,892.00 |
| Sep 30, 2023 | -1,618.00 |
| Jun 30, 2023 | -879.00 |
| Mar 31, 2023 | -6,160.00 |
| Dec 31, 2022 | -1,004.00 |
| Sep 30, 2022 | -1,688.00 |
| Jun 30, 2022 | -411.00 |
| Mar 31, 2022 | 794.00 |
| Dec 31, 2021 | 533.00 |
| Sep 30, 2021 | 3,825.00 |